IGC Pharma, Inc. (IGC)

NYSEAMERICAN: IGC · Real-Time Price · USD

0.2799

-0.0050 (-1.76%)

Oct 9, 2026, 4:00 PM EDT - Market closed

IGC Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	29	23	26	18	48	81
Market Cap Growth	-24.84%	-14.06%	46.64%	-62.80%	-40.34%	321.48%
Enterprise Value	28	23	25	14	37	79
Last Close Price	0.28	0.28	0.40	0.34	0.95	1.79

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Forward PE	-	4.35	4.35	4.35	4.35	4.35
PS Ratio	26.16	17.87	19.65	19.78	122.03	90.43
PB Ratio	3.18	3.59	3.61	1.21	2.03	2.48
P/TBV Ratio	9.01	5.07	4.63	1.31	2.11	2.51
PEG Ratio	-	2.26	2.26	2.26	2.26	2.26

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
EV/Sales Ratio	25.27	17.71	18.91	14.82	93.57	88.35

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Debt / Equity Ratio	0.02	0.04	0.05	0.03	0.03	0.03
Net Debt / Equity Ratio	-0.12	-0.03	-0.12	-0.19	-0.41	-0.41
Net Debt / EBITDA Ratio	0.13	0.02	0.09	0.26	0.71	1.64
Net Debt / FCF Ratio	0.18	0.03	0.16	0.39	1.28	1.11
Asset Turnover	0.11	0.14	0.10	0.04	0.01	0.03
Inventory Turnover	0.55	0.45	0.29	0.15	0.04	0.14
Quick Ratio	0.79	0.21	0.55	1.83	4.53	6.27
Current Ratio	1.32	1.28	1.58	3.41	6.19	9.93
Return on Equity (ROE)	-83.34%	-104.33%	-116.95%	-59.30%	-52.97%	-29.70%
Return on Assets (ROA)	-50.31%	-49.91%	-45.23%	-32.86%	-29.10%	-16.81%
Return on Capital Employed (ROCE)	-98.40%	-114.70%	-129.60%	-75.70%	-59.80%	-26.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Earnings Yield	-22.28%	-31.36%	-49.20%	-63.85%	-31.00%	-10.85%
FCF Yield	-19.44%	-21.61%	-20.20%	-40.83%	-15.89%	-15.11%
Buyback Yield / Dilution	-19.49%	-30.04%	-11.91%	-5.17%	-19.13%	-6.26%

SEC Filings: 10-K · 10-Q